589 - 600 of 7601 results
0.5 CME CREDIT

Your patient is ready for you! In this interactive activity, you will be guided through the case of a patient with COPD via a series of questions and complementary videos. Questions will test your strengths and weaknesses around COPD management, with some questions and feedback tailored directly to your management choices. After each question, you will be presented with learning moments designed to help increase your confidence managing patients with COPD and reducing risk of COPD exacerbations. Please note that any data, indications, and guidelines presented in this activity are current as of 10/1/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In this clinical coffee break, cardiologist Ty Gluckman and endocrinologist Archana Sadhu will explain why glucagon like peptide-1 receptor agonists (GLP-1 RA) are becoming increasingly prominent in diabetes algorithms and cardiovascular risk reduction. Faculty will review the clinical trial data on this class of medications as well as the mechanisms by which GLP-1 RA provide cardiovascular benefit. You will have the opportunity to engage with this activity, viewing resources and testing your knowledge with interactive questions and cases.


0.5 CME CREDIT

Join pulmonologist Dr. Matthew Drake as he discusses the current 2020 GOLD guidelines for treatment of COPD. Using patient case examples, he will outline how to assess patients with COPD to determine the most appropriate evidence-based treatment. Discussion will include which patients will benefit most from inhaled corticosteroids and when to consider triple inhaled therapy with combination of long-acting beta-2-agonist, long acting muscarinic antagonist and inhaled corticosteroids. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 10/9/2020 and they are subject to change as new information is published.


0.33 CME CREDIT

Join pulmonologist Emily Wan, MD as she answers the most pressing questions regarding the management of COPD. In this podcast, Dr. Wan will discuss topics such as when to step-up and step-down therapy, the role of eosinophil count in acute exacerbations, strategies for educating patients on correct inhaler technique (hint – don’t forget about the pharmacist!), how COVID-19 has impacted the management of COPD, and more.


1 CME CREDIT

During this clinical coffee break, Dr. M. Susan Burke, and Elizabeth Haftel, a clinical pharmacist and certified diabetes educator, will discuss practical strategies for using GLP-1 receptor agonists in your patients with diabetes. They will discuss how this class of medications can benefit certain patients. To illustrate the process, faculty will walk through a patient case. You will have the opportunity to engage with this activity, view resources and test your knowledge with interactive questions.


0.75 CME CREDIT

Obesity and Diabetes Update

0.75 CME/MOC
0.75 AANP | 0.28 Pharmacology

Dr. Martin Abrahamson will review the pathophysiology of type 2 diabetes, discuss non-insulin treatments, and explore the most recent guidelines and recommendations for advancing treatment in people with type 2 diabetes to achieve glycemic goals. Dr. Frank Domino will then review a basic framework for counseling patients on weight loss, including a discussion of best evidence on diet, exercise, and appropriate use of medication. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/03/2020, and they are subject to change as new information is published.


1.25 CME CREDITS

National lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, explore novel targets and treatment pathways, and apply the 2018 AHA/ACC Cardiology Cholesterol Guidelines. Learners will have gain practical clinical perspectives during expert case study discussions, including how new treatment options may fit into the current therapeutic landscape.


1 CME CREDIT

Managing Obesity in Primary Care Practice

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

Obesity is the most prevalent chronic disease of the modern era in the U.S. and around the world, affecting both the adult and pediatric population. Although many believe that helping patients to achieve a healthy weight is of minimal complexity, weight regulation and management is a challenging endeavor. In this talk, the faculty will explore the complexities of obesity and offer a range of strategies (behavioral, therapeutic, and surgical) to help you in the quest to address overweight and obesity in your practice.


1 CME CREDIT

With the COVID-19 pandemic moving through the country, it is important for clinicians to have the most up-to-date information. Join this session with Dr. Peter Libby to learn about the cardiovascular complications of COVID-19 and how you can help patients facing these issues. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/3/2020, and they are subject to change as new information is published.


1 CME CREDIT

As the incidence of diabetes and obesity continue to grow, more Americans will develop serious complications and experience premature mortality from cardiometabolic causes. This session will enable you to stay up to date on recent groundbreaking research and management guideline updates that could change the way you treat your patients with diabetes, obesity, and/or dyslipidemia.


1 CME CREDIT

Advanced GI dietitian Bethany Doerfler and GI Health Psychologist Sarah Quinton guide you through nutrition and lifestyle trends related to food intolerances, food allergies and GI health in 2020. Critical differences exist between food intolerances and IgE food allergies or Celiac disease. Consumers are often overwhelmed but interested in the role of dietary manipulation on GI health. This talk will focus on data surrounding the accuracy of testing, recommended diet and lifestyle therapy, and the impact of diet on eating behaviors and quality of life. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/14/2020, and they are subject to change as new information is published.